Is This the Biggest Threat to GW Pharmaceuticals' Marijuana Drug?
The FDA and DEA have signed off on GW Pharmaceuticals' marijuana treatment for epilepsy, but its sales could stall if this other treatment nabs a regulatory OK.
via FOX BUSINESS NEWS https://ift.tt/2DC2npU
No comments:
Post a Comment